Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

8 Apr 2020 12:38

RNS Number : 2439J
Maven Income and Growth VCT 3 PLC
08 April 2020
 

 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at Kintyre House, 205 West George Street, Glasgow, G2 2LW on Wednesday 8 April 2020 at 12.00 noon, all of the Resolutions put to the Meeting were passed.

 

At the record date for the Annual General Meeting, being 6 April 2020, the total number of voting rights in the Company stood at and the total shares in issue were 78,784,600. In accordance with the provisions of E.2.2 of the UK Corporate Governance Code, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 5,033,147 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

4,862,956

142,560

5,940

21,691

5,033,147

2

To approve the Directors' Remuneration Report

4,624,721

142,560

156,417

109,449

5,033,147

3

To approve the Directors' Remuneration Policy

4,512,322

151,471

187,953

181,401

5,033,147

4

To approve a final dividend payment

4,868,734

142,560

6,102

15,751

5,033,147

5

To re-elect Atul Devani as a Director

4,767,122

159,082

65,173

41,770

5,033,147

6

To re-elect David Allan as a Director

4,802,092

159,082

29,464

42,509

5,033,147

7

To re-elect Bill Nixon as a Director

4,775,507

159,082

56,788

41,770

5,033,147

8

To re-elect Keith Pickering as a Director

4,740,079

210,198

47,312

35,558

5,033,147

9

To re-appoint Deloitte LLP as Auditor

4,357,481

183,676

464,034

27,956

5,033,147

10

To authorise the Directors to determine the remuneration of the Auditor

4,803,219

183,676

18,296

27,956

5,033,147

11

To authorise the Directors to allot new shares

4,471,413

192,587

305,062

64,085

5,033,147

12

To authorise disapplication of pre-emption rights

4,241,984

183,676

561,709

45,778

5,033,147

13

To authorise the Company to purchase its own shares

4,308,012

183,676

525,708

15,751

5,033,147

14

To allow a General Meeting to be called on not less than 14 days' notice

4,575,529

231,287

210,580

15,751

5,033,147

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures, along with a summary of questions submitted to the AGM and the Board's responses to them, will be available to view at: www.mavencp.com/migvct3.

 

A copy of the Resolutions passed at the 2020 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

8 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGKKFBNDBKDOQK
Date   Source Headline
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value
13th Oct 20234:56 pmRNSPublication of a Prospectus
25th Aug 20239:38 amRNSIssue of Equity
21st Aug 20233:28 pmRNSStatement re Dividend Investment Scheme
21st Jul 202312:52 pmRNSHalf-year Report
13th Jul 20234:04 pmRNSTransaction in Own Shares
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
30th Jun 20234:22 pmRNSNet Asset Value and Interim Dividend
2nd Jun 20239:41 amRNSIssue of Equity
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202310:15 amRNSIssue of Equity - Dividend Investment Scheme
24th Apr 202312:51 pmRNSResult of AGM
19th Apr 20234:49 pmRNSTransaction in Own Shares
19th Apr 20231:05 pmRNSNet Asset Value - Dividend Investment Scheme
5th Apr 202312:29 pmRNSIssue of Equity
4th Apr 202311:43 amRNSNet Asset Value(s)
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
14th Mar 20234:31 pmRNSAnnual Financial Report
3rd Mar 20239:53 amRNSIssue of Equity
21st Feb 20234:41 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSStatement re Offer for Subscription
8th Feb 202311:06 amRNSDirector/PDMR Shareholding - Replacement
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:19 amRNSDirector/PDMR Shareholding
8th Feb 202310:08 amRNSDirector/PDMR Shareholding
8th Feb 20239:43 amRNSIssue of Equity
1st Feb 20233:23 pmRNSUnaudited NAV and Proposed Final Dividend
12th Dec 20223:41 pmRNSDirectorate Change
12th Dec 20223:34 pmRNSStatement re Director's Other Quoted Directorships
9th Nov 20223:00 pmRNSResult of General Meeting
4th Nov 20222:35 pmRNSTransaction in Own Shares
31st Oct 20223:54 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.